GDPD3
Basic information
Region (hg38): 16:30104810-30113537
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the GDPD3 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 26 | 31 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 1 | |||||
Total | 0 | 0 | 26 | 5 | 1 |
Variants in GDPD3
This is a list of pathogenic ClinVar variants found in the GDPD3 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
16-30104916-G-A | not specified | Uncertain significance (Nov 09, 2022) | ||
16-30104936-G-A | not specified | Uncertain significance (May 30, 2023) | ||
16-30104958-C-T | not specified | Uncertain significance (Jan 16, 2025) | ||
16-30104981-G-A | not specified | Uncertain significance (Jan 23, 2025) | ||
16-30105009-C-T | not specified | Uncertain significance (Sep 15, 2021) | ||
16-30108204-C-A | not specified | Benign (Oct 09, 2017) | ||
16-30108221-C-T | not specified | Uncertain significance (Dec 02, 2021) | ||
16-30108226-T-G | not specified | Uncertain significance (Feb 15, 2023) | ||
16-30108239-G-C | not specified | Uncertain significance (Aug 05, 2024) | ||
16-30108383-C-G | not specified | Uncertain significance (Mar 04, 2025) | ||
16-30108412-C-T | not specified | Uncertain significance (Jan 09, 2024) | ||
16-30108415-G-A | not specified | Uncertain significance (Apr 23, 2024) | ||
16-30111432-G-C | not specified | Uncertain significance (Sep 27, 2024) | ||
16-30111470-G-A | not specified | Uncertain significance (Oct 01, 2024) | ||
16-30111476-C-A | not specified | Likely benign (Mar 01, 2023) | ||
16-30111515-C-T | not specified | Uncertain significance (Dec 01, 2022) | ||
16-30112148-T-G | not specified | Uncertain significance (Apr 09, 2024) | ||
16-30112167-C-T | not specified | Uncertain significance (Dec 19, 2024) | ||
16-30112194-G-A | not specified | Uncertain significance (Mar 11, 2022) | ||
16-30112202-C-T | not specified | Likely benign (Oct 20, 2021) | ||
16-30112215-C-T | not specified | Uncertain significance (Aug 15, 2023) | ||
16-30112310-C-G | not specified | Uncertain significance (Aug 04, 2024) | ||
16-30112323-C-T | not specified | Uncertain significance (Dec 15, 2023) | ||
16-30112325-T-C | not specified | Uncertain significance (Oct 01, 2024) | ||
16-30112327-C-G | not specified | Likely benign (Oct 03, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
GDPD3 | protein_coding | protein_coding | ENST00000406256 | 10 | 9047 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.70e-15 | 0.00716 | 125590 | 0 | 158 | 125748 | 0.000628 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.289 | 187 | 198 | 0.942 | 0.0000126 | 2050 |
Missense in Polyphen | 63 | 71.901 | 0.87621 | 804 | ||
Synonymous | 0.983 | 67 | 78.0 | 0.858 | 0.00000456 | 643 |
Loss of Function | -0.238 | 22 | 20.8 | 1.06 | 0.00000132 | 203 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00113 | 0.00112 |
Ashkenazi Jewish | 0.000199 | 0.000198 |
East Asian | 0.000762 | 0.000761 |
Finnish | 0.0000946 | 0.0000924 |
European (Non-Finnish) | 0.000761 | 0.000756 |
Middle Eastern | 0.000762 | 0.000761 |
South Asian | 0.000656 | 0.000588 |
Other | 0.000657 | 0.000652 |
dbNSFP
Source:
- Function
- FUNCTION: Hydrolyzes lysoglycerophospholipids to produce lysophosphatidic acid (LPA) and the corresponding amines. Shows a preference for 1-O-alkyl-sn-glycero-3-phosphocholine (lyso-PAF) and lysophosphatidylcholine (lyso-PC), and to a lesser extent for lysophosphatidylethanolamine (lyso-PE). Does not display glycerophosphodiester phosphodiesterase activity, since it cannot hydrolyze either glycerophosphoinositol or glycerophosphocholine. {ECO:0000250|UniProtKB:Q99LY2}.;
- Pathway
- Ether lipid metabolism - Homo sapiens (human);Metabolism of lipids;Metabolism;Glycerophospholipid catabolism;PI Metabolism;Phospholipid metabolism
(Consensus)
Intolerance Scores
- loftool
- 0.699
- rvis_EVS
- 0.04
- rvis_percentile_EVS
- 57.15
Haploinsufficiency Scores
- pHI
- 0.119
- hipred
- N
- hipred_score
- 0.144
- ghis
- 0.444
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.114
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Gdpd3
- Phenotype
Zebrafish Information Network
- Gene name
- gdpd3a
- Affected structure
- pigment cell
- Phenotype tag
- abnormal
- Phenotype quality
- decreased amount
Gene ontology
- Biological process
- phospholipid metabolic process;phosphatidylcholine catabolic process;glycerophospholipid catabolic process
- Cellular component
- endoplasmic reticulum membrane;integral component of membrane;perinuclear region of cytoplasm;extracellular exosome
- Molecular function
- lysophospholipase activity;phosphoric diester hydrolase activity;metal ion binding